about
Measurement and predictors of resilience among community-dwelling older womenEthnicity, sleep, mood, and illumination in postmenopausal womenLow-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification TrialThe association between aspirin use and the incidence of colorectal cancer in womenImpact of cyclooxygenase inhibitors in the Women's Health Initiative hormone trials: secondary analysis of a randomized trialLipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart diseaseLow-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification TrialCalcium plus vitamin D supplementation and the risk of colorectal cancerEffects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trialMetabolic syndrome and ischemic heart disease in elderly men and women.Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational StudyCardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary studyMicronized progesterone: a new therapeutic option.Relationships among dietary nutrients and subjective sleep, objective sleep, and napping in women.Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysisOn the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative.Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.Evidence for harm, comment on ‘Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study’.Hypnotics' association with mortality or cancer: a matched cohort study.The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures.Mortality related to actigraphic long and short sleep.Association of morning illumination and window covering with mood and sleep among post-menopausal womenLow-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.Calcium plus vitamin D supplementation and the risk of fractures.Vasomotor symptoms and coronary artery calcium in postmenopausal women.Hormone replacement and the prevention of cardiovascular disease.Live well: a practical and effective low-intensity dietary counseling intervention for use in primary care patients with dyslipidemia--a randomized controlled pilot trial.Chronic venous disease in an ethnically diverse population: the San Diego Population Study.Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis.Paradoxical survival of elderly men with high blood pressure.Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus.Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis.Risk factors for chronic venous disease: the San Diego Population Study.Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events.Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary eventsShould symptomatic menopausal women be offered hormone therapy?Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population.
P50
Q24654663-B69FADE4-C066-4A59-A7BB-ECF0BBF183DAQ24795555-0497ad1e-4213-10df-e0b4-7ad63efdd765Q28194938-228e0eac-4767-c645-10ec-b651dee4bdf1Q28199572-ed846a82-4309-2310-8106-ac2601d90530Q28200604-b352d84d-49a1-15db-8eec-a79a4fc4d802Q28282436-d78a6fc5-47f2-8bf3-c3f6-e46cb11fdfbcQ28296300-019f64ed-4248-6625-97a4-e92e040e1421Q28297713-7ce15ad3-4c1f-04ce-f48c-ab12f0203587Q29615226-b23f1a65-4684-4b91-d41f-dc08eb547689Q32066271-c33b24f6-482e-adbe-229d-11a4047ccb08Q33234184-9e4097c3-466a-d493-ebc0-83555fbb1f23Q33572424-80b90a93-4b46-b8a1-f12d-9760ac11711aQ33616519-4a167741-49f0-6331-1928-41b7abbe3c94Q33641480-1f715c9e-485f-46ed-9bef-a13ef5be9bb5Q33643150-1efdc8a1-40a9-d725-d61f-0fc60df94e34Q33898159-a220f144-4e38-b53b-d98e-77d6682ddca7Q34100632-01dded06-4a84-42d6-bc13-2f79f9021f35Q34120300-0b9b3e4e-44b0-5e51-c519-f154c3e4e693Q34131326-3e94b4f2-450b-ef2b-ee90-94e7c23779a2Q34208463-1875c9d3-47b7-462a-ca6e-d96bf912d374Q34209597-6fe667ab-440f-2936-02e3-82e007d76764Q34257362-353c510a-4690-f2d5-9bd3-103ad68849d7Q34272017-67dc1dac-4e23-7d36-54c6-9bd73526a9c4Q34441036-cc84113e-4ae2-0edc-3707-67e8d5bb27a6Q34443657-c18d1d39-4615-8727-f15f-4697cbd1d2d1Q34492832-c568a4ba-469b-49af-513e-37fb5da92802Q34495055-df706167-4af3-7887-448e-725b555b3f00Q34565965-02c41c6b-450a-8a52-17a2-da26144c8234Q34707898-67bc9c14-4e44-dd53-6ea9-71d8e808f802Q34714869-3fc1b74d-4d7d-7314-ff4b-ce7cb94bbec8Q34846899-ca8f7499-4a96-14b6-31f8-720ae4931496Q35316267-614ebafb-47fd-bbd3-1795-4df65f1c3a09Q35712250-74b6cd94-481e-3d3d-c171-edf41fc0e6cbQ35713227-5f47618f-4459-c9ac-fe23-70383a7affb6Q36062859-ff853af7-4cde-f911-80f8-764cd1d0e3f1Q36065908-d2723f82-4508-621e-d467-bc17d211393cQ36388336-945beb76-4554-5ee3-d655-1d3080d42e76Q36528400-d93533ab-4c40-b6fc-c59a-a82d2b1268abQ36626936-3cd4ab97-49dd-2f4f-b585-e9bdfd5ae89dQ36737889-0afac49b-4bd7-dbae-bd2c-5ac1e25c8168
P50
description
physician and epidemiologist
@en
name
Robert D. Langer
@ast
Robert D. Langer
@en
Robert D. Langer
@es
Robert D. Langer
@nl
type
label
Robert D. Langer
@ast
Robert D. Langer
@en
Robert D. Langer
@es
Robert D. Langer
@nl
altLabel
Robert D Langer
@en
Robert Langer
@en
prefLabel
Robert D. Langer
@ast
Robert D. Langer
@en
Robert D. Langer
@es
Robert D. Langer
@nl
P69
P1153
57203044163
7402409221
P2038
Robert_Langer